{"id":"W3087827200","doi":"10.1016/j.annonc.2020.08.431","title":"329P Ribociclib (RIB) in patients (pts) with HR+/HER2− advanced breast cancer (ABC) and resistance to prior endocrine therapy (ET) in the MONALEESA (ML) -3 and -7 trials","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Fulvestrant; Breast cancer; Hazard ratio; Goserelin; Placebo; Progression-free survival; Cancer; Surgery; Gastroenterology; Oncology; Tamoxifen; Chemotherapy; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006014297,0.0002323368,0.0009572156,0.0001135974,0.00003608177,0.000009024226,0.0001467555,0.00007368742,0.00004511238],"category_scores_gemma":[0.0002301916,0.0001514858,0.0000466701,0.0004096763,0.0001966163,0.0001551802,0.00004985796,0.0002609448,0.000001040984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006941341,"about_ca_system_score_gemma":0.0002105677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001828219,"about_ca_topic_score_gemma":0.001454273,"domain_scores_codex":[0.9980434,0.0003657903,0.0005669249,0.0004265043,0.0002433048,0.000354083],"domain_scores_gemma":[0.9986581,0.000488278,0.0002847112,0.0002226498,0.0001948478,0.000151404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05709458,0.000890223,0.2740665,0.0001799304,0.0002053572,0.00009684407,0.008449176,0.00007913356,0.003442782,0.0007045834,0.0004861921,0.6543047],"study_design_scores_gemma":[0.01890122,0.004266716,0.9018667,0.0002828139,0.00002786572,0.00002810658,0.0007383241,0.000005209932,0.00128224,0.0005498043,0.07184275,0.0002082661],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9128686,0.004192913,0.00001769766,0.08110811,0.00003319756,0.001270405,0.0001004743,0.00001559581,0.0003930097],"genre_scores_gemma":[0.9768491,0.003202651,0.001209708,0.01833183,0.00008196643,0.0002367635,0.00000920836,0.00003005619,0.00004869521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6540965,"threshold_uncertainty_score":0.6177412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07957722803001016,"score_gpt":0.4040811847777209,"score_spread":0.3245039567477107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}